Non-invasive Cardiac Index in Children
Launched by LASZLO VUTSKITS · Oct 16, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how well two non-invasive tools can measure heart function in young children who are under anesthesia for surgery. The tools being tested are called transthoracic echocardiography and electrical cardiometry. The goal is to see if these tools provide similar readings of how well the heart is pumping blood, which is important for ensuring the child remains safe during surgery.
To participate in this trial, children must be between 0 and 17 months old and scheduled for surgery that will take more than 30 minutes under general anesthesia. They should also be healthy enough for surgery (classified as ASA 1-3) and have a post-menstrual age of at least 36 weeks. Parents or guardians must be able to read and understand French and give permission for their child to participate. Children with certain heart conditions, allergies to adhesives, or those undergoing specific types of surgery may not be eligible. If your child qualifies, they can expect a non-invasive procedure that simply involves placing sensors on their body to measure heart function during their surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age 0 to 17 months included
- • 2. Greater than 36 weeks post-menstrual age (PMA) on the day of the study
- • 3. Undergoing general anaesthesia for surgery that is expected to last more than 30 minutes (combines anaesthesia and surgical time)
- • 4. Parental/guardian understands and reads French and permission (informed consent) obtained
- • 5. ASA 1-3 status
- Exclusion Criteria:
- • 1. Structural/anatomical anomaly or other circumstances (e.g., patient positioning) making it difficult to apply the sensors to the body or limiting the feasibility of the TTE
- • 2. Any Congenital heart diseases
- • 3. Known allergy to electrodes' glue
- • 4. Thoracic, cardiac and head surgery
- • 5. Traumatic surgery with hemodynamic instability
About Laszlo Vutskits
Laszlo Vutskits is a dedicated clinical trial sponsor focused on advancing medical research and improving patient outcomes through innovative therapies. With a commitment to rigorous scientific standards and ethical practices, the organization collaborates with leading healthcare professionals and research institutions to design and conduct clinical trials across various therapeutic areas. By leveraging cutting-edge technologies and a patient-centered approach, Laszlo Vutskits aims to bring new and effective treatment options to market, ultimately enhancing the quality of care and addressing unmet medical needs.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Geneva, , Switzerland
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported